Your browser doesn't support javascript.
loading
Apixaban in Japanese patients with cancer-associated venous thromboembolism: a multi-center phase II trial.
Imamura, Yoshinori; Otsui, Kazunori; Mori, Kenta; Kitagawa, Koichi; Okada, Hideaki; Hata, Akito; Hayashi, Hidetoshi; Nose, Taku; Ohata, Shinya; Miyata, Yoshiharu; Funakoshi, Yohei; Toyoda, Masanori; Yakushijin, Kimikazu; Kiyota, Naomi; Matsuoka, Hiroshi; Minami, Hironobu.
Affiliation
  • Imamura Y; Medical Oncology/Hematology, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan. yimamura@med.kobe-u.ac.jp.
  • Otsui K; General Internal Medicine, Kobe University Hospital, Kobe, Japan.
  • Mori K; General Internal Medicine, Kobe University Hospital, Kobe, Japan.
  • Kitagawa K; Medical Oncology, Kobe Minimally Invasive Cancer Center, Kobe, Japan.
  • Okada H; Medical Oncology, Kobe Minimally Invasive Cancer Center, Kobe, Japan.
  • Hata A; Thoracic Oncology, Kobe Minimally Invasive Cancer Center, Kobe, Japan.
  • Hayashi H; Medical Oncology, Kindai University Faculty of Medicine, Osakasayama, Japan.
  • Nose T; Medical Oncology/Hematology, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Ohata S; Medical Oncology/Hematology, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Miyata Y; Medical Oncology/Hematology, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Funakoshi Y; Medical Oncology/Hematology, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Toyoda M; Medical Oncology/Hematology, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Yakushijin K; Medical Oncology/Hematology, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Kiyota N; Medical Oncology/Hematology, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
  • Matsuoka H; Cancer Center, Kobe University Hospital, Kobe, Japan.
  • Minami H; Medical Oncology/Hematology, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
Int J Hematol ; 115(4): 499-507, 2022 Apr.
Article de En | MEDLINE | ID: mdl-35079961
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Thromboembolisme veineux / Tumeurs Type d'étude: Clinical_trials / Etiology_studies / Risk_factors_studies Limites: Aged / Humans Pays/Région comme sujet: Asia Langue: En Journal: Int J Hematol Sujet du journal: HEMATOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Japon Pays de publication: Japon
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Thromboembolisme veineux / Tumeurs Type d'étude: Clinical_trials / Etiology_studies / Risk_factors_studies Limites: Aged / Humans Pays/Région comme sujet: Asia Langue: En Journal: Int J Hematol Sujet du journal: HEMATOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Japon Pays de publication: Japon